. home.aspx

home.aspx
   

FOR AI-ENABLED DRUG DISCOVERIES, WHO OWNS THE SCIENCE?

July 08, 2019

Dealing with intellectual property issues presents a challenge, of sorts, for drug developers. The last in our series. There is no doubt that artificial intelligence is greatly influencing the field of drug discovery. For the past several days we’ve heard from a number of scientists, from the academic and commercial sides, who are using or developing AI tools for drug discovery research. come ethical considerations. Last week, John Mitchell, a theoretical chemist at the University of St. Andrews, talked about the challenges of privacy and job attrition that AI presents.